Promising new photon detection concepts for high-resolution clinical and preclinical PET.
The ability of PET to visualize and quantify regions of low concentration of PET tracer representing subtle cellular and molecular signatures of disease depends on relatively complex biochemical, biologic, and physiologic factors that are challenging to control, as well as on instrumentation performance parameters that are, in principle, still possible to improve on. Thus, advances to the latter can somewhat offset barriers of the former. PET system performance parameters such as spatial resolution, contrast resolution, and photon sensitivity contribute significantly to PET's ability to visualize and quantify lower concentrations of signal in the presence of background. In this report we present some technology innovations under investigation toward improving these PET system performance parameters. We focus particularly on a promising advance known as 3-dimensional position-sensitive detectors, which are detectors capable of distinguishing and measuring the position, energy, and arrival time of individual interactions of multi-interaction photon events in 3 dimensions. If successful, these new strategies enable enhancements such as the detection of fewer diseased cells in tissue or the ability to characterize lower-abundance molecular targets within cells. Translating these advanced capabilities to the clinic might allow expansion of PET's roles in disease management, perhaps to earlier stages of disease. In preclinical research, such enhancements enable more sensitive and accurate studies of disease biology in living subjects.
Molecular Imaging Instrumentation Laboratory, Departments of Radiology, Physics, and Electrical Engineering, Stanford University, Stanford, CA, USA. cslevin@stanford.edu
Craig S
CS
Levin
D000818:Animals; D006801:Humans; D017785:Photons; D049268:Positron-Emission Tomography / Q000295:instrumentation / Q000379:methods*; D012588:Scintillation Counting / Q000295:instrumentation / Q000379:methods*